Key result
Mantle irradiation for Hodgkin's disease was associated with a 5.5% incidence of morbid cardiac events and a 2.8-fold increased relative risk of cardiac death compared to the US population.
Why the study?
Does mantle irradiation for Hodgkin's disease increase the risk of morbid cardiac events compared to the general population?
Cohort (n=326)
No
Does mantle irradiation for Hodgkin's disease increase the risk of morbid cardiac events compared to the general population?
Mantle irradiation for Hodgkin's disease is associated with a significantly increased risk of premature coronary artery disease and morbid cardiac events, highlighting the need for cardiac shielding, monitoring, and risk factor modification.
Answers are grounded in this paper and cite their sources.
Supports cardiac surveillance in Hodgkin survivors after mantle irradiation; leaves open risk reduction with modern techniques.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
King et al. (1996) conducted a cohort in Hodgkin's disease (n=326). Mantle irradiation vs. General US population was evaluated on Morbid cardiac events (cardiac death, nonfatal myocardial infarction, and angina pectoris) (RR 2.8). Mantle irradiation for Hodgkin's disease was associated with a 5.5% incidence of morbid cardiac events and a 2.8-fold increased relative risk of cardiac death compared to the US population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: